StockData
AEMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31

AETHLON MEDICAL INC

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.16+0.01 (+0.19%)

Close on Oct 19, 2026

Market cap
$1.99M
P/E (TTM)
–
Dividend yield
–

AETHLON MEDICAL INC revenue by segment

By business segment

RevenueFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015% of revenueYoY
Aethlon [Member]$294.17K$659.10K$650.19K$229.63K$149.63K–––100.0%-55.4%
ESI [Member]$0$0$0$0$0–––0.0%–
Operating incomeFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015YoY
ESI [Member]-$23.97K-$23.95K-$30.47K-$123.92K-$101.40K-$153.06K-$431.43K-$911.68K+0.1%
Aethlon [Member]-$10.40M-$7.87M-$5.90M-$5.88M-$4.73M-$5.95M-$3.95M-$3.08M+32.1%

By product or service

RevenueFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015% of revenueYoY
Govt Contract And Grant Revenue [Member]$294.17K$659.10K$650.19K–––––100.0%-55.4%
Government Contract Revenue [Member]––$650.19K$229.63K$149.63K–––––

By region

From the segment and revenue-disaggregation notes of Aethlon Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.